Do we need a new cut-off for FIB-4 in the metabolic dysfunction-associated fatty liver disease era?

被引：4
|
作者：
Park, Huiyul [1 ]
Yoon, Eileen L. [2 ]
Cho, Seon [3 ]
Nah, Eun-Hee [3 ]
Jun, Dae Won [2 ]
机构：
[1] Eulji Univ, Sch Med, Uijeongbu Eulji Med Ctr, Dept Family Med, Daejeon, South Korea
[2] Hanyang Univ, Hanyang Univ Hosp, Coll Med, Dept Internal Med, Seoul, South Korea
[3] Hlth Promot Res Inst, Dept Lab Med, Seoul, South Korea
来源：
JOURNAL OF HEPATOLOGY | 2021年 / 75卷 / 03期
关键词：
DIAGNOSIS;
D O I：
10.1016/j.jhep.2021.05.035
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：725 / 726
页数：2
相关论文
共 50 条
  • [1] DO WE NEED A NEW CUT-OFF FOR FIB-4 IN THE METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE ERA?
    Ahn, Sang Bong
    Park, Huiyul
    Yoon, Eileen
    Jun, Dae Won
    An, Ji Hyun
    Sohn, Joo Hyun
    Kim, Mimi
    Kang, Bo-Kyeong
    Lee, Chul-Min
    [J]. HEPATOLOGY, 2021, 74 : 1005A - 1005A
  • [2] FIB-4 cut-off should be re-evaluated in patients with metabolic associated fatty liver disease (MAFLD)
    Wu, Yinlian
    Kumar, Rahul
    Huang, Jiaofeng
    Wang, Mingfang
    Zhu, Yueyong
    Lin, Su
    [J]. JOURNAL OF HEPATOLOGY, 2021, 74 (01) : 247 - 248
  • [3] Reply to: "FIB-4 cut-off should be re-evaluated in patients with metabolic associated fatty liver disease (MAFLD)"
    Tsochatzis, Emmanuel A.
    Srivastava, Ankur
    Rosenberg, William
    [J]. JOURNAL OF HEPATOLOGY, 2021, 74 (01) : 248 - 249
  • [4] FIB-4 First in the Diagnostic Algorithm of Metabolic-Dysfunction-Associated Fatty Liver Disease in the Era of the Global Metabodemic
    Sumida, Yoshio
    Yoneda, Masashi
    Tokushige, Katsutoshi
    Kawanaka, Miwa
    Fujii, Hideki
    Yoneda, Masato
    Imajo, Kento
    Takahashi, Hirokazu
    Eguchi, Yuichiro
    Ono, Masafumi
    Nozaki, Yuichi
    Hyogo, Hideyuki
    Koseki, Masahiro
    Yoshida, Yuichi
    Kawaguchi, Takumi
    Kamada, Yoshihiro
    Okanoue, Takeshi
    Nakajima, Atsushi
    [J]. LIFE-BASEL, 2021, 11 (02): : 1 - 20
  • [5] FIB-4 as a screening and disease monitoring method in pre-fibrotic stages of metabolic dysfunction-associated fatty liver disease (MASLD)
    Albert, Stewart G.
    Wood, Emily M.
    [J]. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2024, 38 (07)
  • [6] FIB-4 Index and Liver Stiffness Measurement are Potential Predictors of Atherosclerosis in Metabolic Dysfunction-Associated Steatotic Liver Disease
    Kubotsu, Yoshihito
    Sakamoto, Yoshiko
    Tago, Motoko
    Chihara, Atsuko
    Norita, Misa
    Inadomi, Chika
    Inoue, Kaori
    Takayanagi, Hiroki
    Tanaka, Kenichi
    Isoda, Hiroshi
    Kuwashiro, Takuya
    Oeda, Satoshi
    Shiratori, Toshiyasu
    Anzai, Keizo
    Node, Koichi
    Takahashi, Hirokazu
    [J]. JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2024,
  • [7] Comparison of diagnostic performance between FIB-4 and NFS in metabolic-associated fatty liver disease era
    Park, Huiyul
    Yoon, Eileen L.
    Kim, Mimi
    Lee, Jonghyun
    Kim, Jung-Hwan
    Cho, Seon
    Jun, Dae Won
    Nah, Eun-Hee
    [J]. HEPATOLOGY RESEARCH, 2022, 52 (03) : 247 - 254
  • [8] Comparison of diagnostic performance between FIB-4 and NFS in metabolic-associated fatty liver disease era
    Jun, Dae Won
    Yoon, Eileen
    Ahn, Sang Bong
    Park, Huiyul
    Lee, Hyo Young
    Oh, Hyunwoo
    Sohn, Joo Hyun
    Kang, Bo-Kyeong
    Kim, Mi Mi
    Lee, Chul-min
    [J]. JOURNAL OF HEPATOLOGY, 2022, 77 : S438 - S438
  • [9] Diagnostic performance of new BAST score versus FIB-4 index in predicating of the liver fibrosis in patients with metabolic dysfunction-associated steatotic liver disease
    Helal, Eman
    Elgebaly, Fatma
    Mousa, Nasser
    Elbaz, Sherif
    Abdelsalam, Mostafa
    Abdelkader, Eman
    El-Sehrawy, Amr
    El-wakeel, Niveen
    El-Emam, Ola
    Hashem, Manal
    Elmetwalli, Alaa
    Mansour, Shimaa
    [J]. EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2024, 29 (01)
  • [10] From metabolic dysfunction-associated fatty liver disease to metabolic dysfunction-associated steatotic liver disease: Controversy and consensus
    Chen, Li
    [J]. WORLD JOURNAL OF HEPATOLOGY, 2023, 15 (12) : 1253 - 1257
12345